The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Skeletal PET with18F-Fluoride: Applying New Technology to an Old Tracer
Open accessAbstract
Although (18)F-labeled NaF was the first widely used agent for skeletal scintigraphy, it quickly fell into disuse after the introduction of (99m)Tc-labeled bone-imaging agents. Recent comparative studies have demonstrated that (18)F-fluoride PET is more accurate than (99m)Tc-diphosphonate SPECT for identifying both malignant and benign lesions of the skeleton. Combining (18)F-fluoride PET with other imaging, such as CT, can improve the specificity and overall accuracy of skeletal (18)F-fluoride PET and probably will become the routine clinical practice for (18)F-fluoride PET. Although (18)F-labeled NaF and (99m)Tc-diphosphonate have a similar patient dosimetry, (18)F-fluoride PET offers shorter study times (typically less than 1 h), resulting in a more efficient workflow, improved patient convenience, and faster turnarounds of reports to the referring physicians. With the widespread availability of PET scanners and the improved logistics for the delivery of (18)F radiopharmaceuticals, prior limitations to the routine use of (18)F-fluoride bone imaging have largely been overcome. The favorable imaging performance and the clinical utility of (18)F-fluoride PET, compared with (99m)Tc-diphosphonate scintigraphy, support the reconsideration of (18)F-fluoride as a routine bone-imaging agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Padhani, A. R. (2006) · Cancer Imaging · doi:10.1102/1470-7330.2006.9018 · Cited by 47
RetractedHypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662
Thompson, I. M., Pauler, D. K., Goodman, P. J., Tangen, C. M., Lucia, M. S., Parnes, H. L., Minasian, L. M., Ford, L. G., Lippman, S. M., Crawford, E. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031918 · Cited by 2,446
(1999) · PubMed · Cited by 2,204
Imaging proliferation in vivo with [F-18]FLT and positron emission tomography
Shields, A. F., Grierson, J. R., Dohmen, B. M., Machulla, H.-J., Stayanoff, J. C., Lawhorn-Crews, J. M., Obradovich, J. E., Muzik, O., & Mangner, T. J. (1998) · Nature Medicine · doi:10.1038/3337 · Cited by 1,204
Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology
Semenza, G. L. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02090-1 · Cited by 930
Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.
Ryan, H. E., Poloni, M., McNulty, W., Elson, D., Gassmann, M., Arbeit, J. M., & Johnson, R. S. (2000) · PubMed · Cited by 890
Even‐Sapir, E., Metser, U., Mishani, E., Lievshitz, G., Lerman, H., & Leibovitch, I. (2006) · PubMed · Cited by 795
Gittes, R. F. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101243240406 · Cited by 738
(1991) · Annals of the ICRP · doi:10.1016/0146-6453(91)90017-b · Cited by 565
Rasey, J. S., Koh, W.-J., Evans, M. L., Peterson, L. M., Lewellen, T. K., Graham, M. M., & Krohn, K. A. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00325-2 · Cited by 562
Rischin, D., Hicks, R. J., Fisher, R., Binns, D., Corry, J., Porceddu, S., & Peters, L. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2878 · Cited by 541
Eschmann, S. M., Paulsen, F., Reimold, M., Dittmann, H., Welz, S., Reischl, G., Machulla, H.-J., & Bares, R. (2005) · PubMed · Cited by 454
Clinical Applications of PET in Brain Tumors
Chen, W. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.037689 · Cited by 449
Fluorine-18: a new isotope for bone scanning.
Blau, M., Nagler, W., & BENDER, M. A. (1962) · PubMed · Cited by 430
Tumor Hypoxia Has Independent Predictor Impact Only in Patients With Node-Negative Cervix Cancer
Fyles, A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.680 · Cited by 397
Chen, W., Delaloye, S., Silverman, D. H. S., Geist, C., Czernin, J., Sayre, J., Satyamurthy, N., Pope, W., Lai, A., Phelps, M. E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.5825 · Cited by 393
(2008) · Annals of the ICRP · doi:10.1016/j.icrp.2008.08.003 · Cited by 390
Hypoxia and Glucose Metabolism in Malignant Tumors
Rajendran, J. G., Mankoff, D. A., O’Sullivan, F., Peterson, L. M., Schwartz, D. L., Conrad, E. U., Spence, A. M., Muzi, M., Farwell, D. G., & Krohn, K. A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0688-3 · Cited by 390
Rajendran, J. G., Schwartz, D. L., O'Sullivan, J., Peterson, L. M., Ng, P., Scharnhorst, J., Grierson, J. R., & Krohn, K. A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1773 · Cited by 354
PROSTATE SPECIFIC ANTIGEN ONLY PROGRESSION OF PROSTATE CANCER
MOUL, J. W. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67511-8 · Cited by 350
Schirrmeister, H., Guhlmann, A., Elsner, K., Kotzerke, J., Glatting, G., Rentschler, M., Neumaier, B., Träger, H., Nüssle, K., & Reske, S. N. (1999) · PubMed · Cited by 329
Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers.
DeGrado, T. R., BALDWIN, S. W., Wang, S., Orr, M. D., Liao, R., Friedman, H. S., Reiman, R. E., Price, D. T., & Coleman, R. E. (2001) · PubMed · Cited by 329
Imaging of Cell Proliferation: Status and Prospects
Bading, J. R., & Shields, A. F. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.046391 · Cited by 320
Cimitan, M., Bortolus, R., Morassut, S., Canzonieri, V., Garbeglio, A., Baresic, T., Borsatti, E., Drigo, A., & Trovò, M. G. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0150-2 · Cited by 312
Positron Emission Tomography As an Imaging Biomarker
Weber, W. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.6068 · Cited by 312
Evaluation of [18F]-choline PET/CT for staging and restaging of prostate cancer
Husarik, D. B., Miralbell, R., Dubs, M., John, H., Giger, O. T., Gelet, A., Cservenyàk, T., & Hany, T. F. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0552-9 · Cited by 295
Koh, W.-J., Bergman, K. S., Rasey, J. S., Peterson, L. M., Evans, M. L., Graham, M. M., Grierson, J. R., Lindsley, K. L., Lewellen, T. K., Krohn, K. A., et al. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00170-4 · Cited by 288
Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate
Blake, G. M., Park-Holohan, S.-J., Cook, G. J. R., & Fogelman, I. (2001) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2001.18742 · Cited by 286
Schirrmeister, H., Guhlmann, A., Kotzerke, J., Santjohanser, C., Kühn, T., Kreienberg, R., Messer, P., Nüssle, K., Elsner, K., Glatting, G., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2381 · Cited by 283
Hypoxia Positron Emission Tomography Imaging With 18F-Fluoromisonidazole
Lee, S. T., & Scott, A. M. (2007) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2007.07.001 · Cited by 283
Nordsmark, M., & Overgaard, J. (2000) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(00)00223-1 · Cited by 281
Kenny, L., Coombes, R. C., Vigushin, D. M., Al-Nahhas, A., Shousha, S., & Aboagye, E. O. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0379-4 · Cited by 275
Blau, M., Ganatra, R., & Bender, M. A. (1972) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(72)80005-9 · Cited by 272
Schirrmeister, H., Glatting, G., Hetzel, J., Nüssle, K., Arslandemir, C., Buck, A. K., Dziuk, K., Gabelmann, A., Reske, S. N., & Hetzel, M. (2001) · PubMed · Cited by 257
PET imaging of brain tumor with [methyl-11C]choline.
Hara, T., Kosaka, N., Shinoura, N., & Kondo, T. (1997) · PubMed · Cited by 257
Hofer, C., Laubenbacher, C., Block, T., Breul, J., Härtung, R., & Schwaiger, M. (1999) · European Urology · doi:10.1159/000019923 · Cited by 252
Rajendran, J. G., Wilson, D. C., Conrad, E. U., Peterson, L. M., Bruckner, J. D., Rasey, J. S., Chin, L. K., Hofstrand, P. D., Grierson, J. R., Eary, J. F., et al. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1096-7 · Cited by 252
Imaging prostate cancer with 11C-choline PET/CT.
Reske, S. N., Blumstein, N. M., Neumaier, B., Gottfried, H., Finsterbusch, F., Kocot, D., Möller, P., Glatting, G., & Perner, S. (2006) · PubMed · Cited by 250
Lee, N. Y., Mechalakos, J. G., Nehmeh, S., Lin, Z., Squire, O. D., Cai, S., Chan, K., Zanzonico, P. B., Greco, C., Ling, C. C., et al. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.06.039 · Cited by 235
Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole.
Valk, P. E., Mathis, C. A., Prados, M. D., Gilbert, J. C., & Budinger, T. F. (1992) · PubMed · Cited by 224
Pio, B. S., Park, C. K., Pietras, R., Hsueh, W.-A., Satyamurthy, N., Pegram, M. D., Czernin, J., Phelps, M. E., & Silverman, D. H. S. (2006) · Molecular Imaging and Biology · doi:10.1007/s11307-005-0029-9 · Cited by 223
Bruehlmeier, M., Roelcke, U., Schubiger, P. A., & Ametamey, S. M. (2004) · PubMed · Cited by 214
PET in oncology: Will it replace the other modalities?
Hoh, C. K., Schiepers, C., Seltzer, M. A., Gambhir, S. S., Silverman, D. H. S., Czernin, J., Maddahi, J., & Phelps, M. E. (1997) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(97)80042-6 · Cited by 211
Reproducibility of Intratumor Distribution of 18F-Fluoromisonidazole in Head and Neck Cancer
Nehmeh, S. A., Lee, N. Y., Schröder, H., Squire, O., Zanzonico, P. B., Erdi, Y. E., Greco, C., Mageras, G., Pham, H. S., Larson, S. M., et al. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.08.036 · Cited by 210
Schöder, H., Herrmann, K., Gönen, M., Hricak, H., Eberhard, S., Scardino, P., Scher, H. I., & Larson, S. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0249 · Cited by 202
Birner, P., Gatterbauer, B., Oberhuber, G., Schindl, M., Rössler, K., Prodinger, A., Budka, H., & Hainfellner, J. A. (2001) · Cancer · doi:10.1002/1097-0142(20010701)92:1<165::aid-cncr1305>3.0.co;2-f · Cited by 195
Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET.
Kwee, S. A., Wei, H. M., Sesterhenn, I. A., Yun, D., & Coel, M. N. (2006) · PubMed · Cited by 192
Heinisch, M., Dirisamer, A., Loidl, W., Stoiber, F., Gruy, B., Haim, S., & Langsteger, W. (2006) · Molecular Imaging and Biology · doi:10.1007/s11307-005-0023-2 · Cited by 191
The OxyLite: a fibre-optic oxygen sensor.
Griffiths, J. R., & Robinson, S. P. (1999) · The British Journal of Radiology · doi:10.1259/bjr.72.859.10624317 · Cited by 186
Molecular Imaging of Proliferation in Malignant Lymphoma
Buck, A. K., Bommer, M., Stilgenbauer, S., Juweid, M., Glatting, G., Schirrmeister, H., Mattfeldt, T., Tepsic, D., Bunjes, D., Mottaghy, F. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1955 · Cited by 185
Mardones, R. M., Gonzalez, C., Chen, Q., Zobitz, M., Kaufman, K. R., & Trousdale, R. T. (2006) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.e.01024 · Cited by 183
Messa, C. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.4.949 · Cited by 179
Cher, L., Murone, C., Lawrentschuk, N., Ramdave, S., Papenfuss, A. T., Hannah, A., O'Keefe, G. J., Sachinidis, J. I., Berlangieri, S. U., Fabinyi, G., et al. (2006) · PubMed · Cited by 175
Hetzel, M., Arslandemir, C., König, H., Buck, A. K., Nüssle, K., Glatting, G., Gabelmann, A., Hetzel, J., Hombach, V., & Schirrmeister, H. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.12.2206 · Cited by 170
Thorwarth, D., Eschmann, S.-M., Scheiderbauer, J., Paulsen, F., & Alber, M. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-152 · Cited by 169
(2003) · PubMed · Cited by 167
PET imaging of cellular proliferation
Mankoff, D. A., Shields, A. F., & Krohn, K. A. (2005) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2004.09.005 · Cited by 161
Herrmann, K., Wieder, H. A., Buck, A. K., Schöffel, M., Krause, B., Fend, F., Schuster, T., Büschenfelde, C. M. Z., Wester, H., Duyster, J., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3025 · Cited by 153
Cherk, M. H., Foo, S. S., Poon, A. M. T., Knight, S. R., Murone, C., Papenfuss, A. T., Sachinidis, J. I., Saunder, T., O'Keefe, G. J., & Scott, A. M. (2006) · PubMed · Cited by 149
Roivainen, A., Forsback, S. J., Grönroos, T. J., et al. (2000) · European Journal of Nuclear Medicine · doi:10.1007/pl00006658 · Cited by 146
Salskov, A., Tammisetti, V. S., Grierson, J. R., & Vesselle, H. J. (2007) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2007.08.001 · Cited by 143
Hicks, R. J., Rischin, D., Fisher, R., Binns, D., Scott, A. M., & Peters, L. J. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1880-2 · Cited by 141
Eschmann, S. M., Paulsen, F., Bedeshem, C., Machulla, H., Hehr, T., Bamberg, M., & Bares, R. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.05.014 · Cited by 120
Bentzen, L., Keiding, S., Nordsmark, M., Falborg, L., Hansen, S. B., Keller, J. O., Nielsen, O. S., & Overgaard, J. (2003) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(03)00081-1 · Cited by 118
Sanz, Sanz, Robles, J. E., Giménez, Arocena, Sánchez, Sánchez, Rodriguez‐Rubio, Rosell, Richter, et al. (1999) · British Journal of Urology · doi:10.1046/j.1464-410x.1999.00349.x · Cited by 109
Advances in Evaluation of Primary Brain Tumors
Chen, W., & Silverman, D. H. S. (2008) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2008.02.005 · Cited by 89
Bache, M., Kappler, M., Said, H. M., Staab, A., & Vordermark, D. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708783497391 · Cited by 87
Semiquantitative immunohistochemical analysis for hypoxia in human tumors
Raleigh, J. A., Chou, S.-C., Bono, E. L., Thrall, D. Ε., & Varia, M. A. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01505-4 · Cited by 82
Thorwarth, D., Eschmann, S. M., Paulsen, F., & Alber, M. L. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.12.037 · Cited by 79
Fluorine-18-fluoromisonidazole radiation dosimetry in imaging studies.
Graham, M. M., Peterson, L. M., Link, J. M., Evans, M. L., Rasey, J. S., Koh, W., Caldwell, J. H., & Krohn, K. A. (1997) · PubMed · Cited by 76
He, F., Deng, X., Wen, B., Liu, Y., Sun, X., Xing, L., Minami, A., Huang, Y., Chen, Q., ZANZONICO, P. B., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0677 · Cited by 70
Early assessment of therapy response in malignant lymphoma with the thymidine analogue [18F]FLT
Buck, A. K., Kratochwil, C., Glatting, G., Juweid, M. E., Bommer, M., Tepsic, D., Vogg, A. T. J., Mattfeldt, T., Neumaier, B., Mӧller, P., et al. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0452-z · Cited by 65
From anatomical to biological target volumes: the role of PET in radiation treatment planning
Schinagl, D. A. X., Kaanders, J. H. A. M., & Oyen, W. J. G. (2006) · Cancer Imaging · doi:10.1102/1470-7330.2006.9017 · Cited by 37
Positron Emission Tomography Imaging of Cell Proliferation in Oncology
Kenny, L. M., Aboagye, E. O., & Price, P. (2003) · Clinical Oncology · doi:10.1016/j.clon.2003.10.009 · Cited by 32
A Physiologic Imaging Pilot Study of Breast Cancer Treated with AZD2171
Miller, K. D., Miller, M. A., Mehrotra, S., Agarwal, B., Mock, B. H., Zheng, Q., Badve, S., Hutchins, G. D., & Sledge, G. W. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0219 · Cited by 31
Caldwell, J. H., Revenaugh, J. R., Martin, G. V., Johnson, P. M., Rasey, J. S., & Krohn, K. A. (1995) · PubMed · Cited by 29
Cited by
Coronary Arterial 18F-Sodium Fluoride Uptake
Dweck, M. R., Chow, M. W. L., Joshi, N. V., Williams, M. C., Jones, C., Fletcher, A. M., Richardson, H., White, A., McKillop, G., van Beek, E. J. R., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.12.037 · Cited by 488
Molecular Mechanisms of Bone 18F-NaF Deposition
Czernin, J., Satyamurthy, N., & Schiepers, C. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.077933 · Cited by 352
Dweck, M. R., Jones, C., Joshi, N. V., Fletcher, A. M., Richardson, H., White, A., Marsden, M., Pessotto, R., Clark, J. C., Wallace, W. A., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.051052 · Cited by 337
Cho, S. Y., Gage, K. L., Mease, R. C., Senthamizhchelvan, S., Holt, D. P., Jeffrey-Kwanisai, A., Endres, C. J., Dannals, R. F., Sgouros, G., Lodge, M., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.104661 · Cited by 279
Metadata
- Authors
- Grant, F. D., Fahey, F. H., Packard, A. B., Davis, R. T., Alavi, A., & Treves, S. T.
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2007-12-12
- Volume
- 49
- Issue
- 1
- Pages
- 68-78
- ISSN
- 0161-5505 (ISSN-L)
- 2159-662X
- OpenAlex
- W2158110141
- Cited by
- 520
- References
- 78
- FWCI
- 13.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.